- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 303/38 - Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 303/38
Total number of patents in this class: 59
10-year publication summary
|
6
|
5
|
7
|
2
|
3
|
0
|
6
|
0
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Brigham and Women's Hospital, Inc. | 2296 |
6 |
| Board of Regents, The University of Texas System | 6161 |
4 |
| Apeel Technology, Inc., DBA Apeel Sciences, Inc. | 182 |
4 |
| The Regents of the University of California | 20868 |
3 |
| Dorphan S.A. | 6 |
3 |
| BASF Agro B.V. | 208 |
2 |
| The Brigham & Women's Hospital, Inc. | 36 |
2 |
| Givaudan SA | 1985 |
2 |
| Max-delbrueck-centrum fuer Molekulare Medizin (mdc) | 2 |
2 |
| Salvia Sciences, Inc. | 2 |
2 |
| The University of Tokyo | 4386 |
2 |
| ZSCHIMMER & Schwarz, Inc. | 11 |
2 |
| Max-delbrueck-centrum fuer Molekulare Medizin | 24 |
2 |
| Centre National de La Recherche Scientifique | 11092 |
1 |
| Massachusetts Institute of Technology | 10290 |
1 |
| Sumitomo Chemical Company, Limited | 8967 |
1 |
| DSM IP Assets B.V. | 5386 |
1 |
| Avant Garde Therapeutics and Technologies LLC | 3 |
1 |
| Cytec Surface Specialties S.A. | 32 |
1 |
| Daiichi Sankyo Company, Limited | 1889 |
1 |
| Other owners | 16 |